Related Experiment Video

Updated: Oct 26, 2026

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma
10:02

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma

Published on: June 2, 2023

Beta-interferon plus inosiplex in the treatment of subacute sclerosing panencephalitis

B Anlar1, K Yalaz, G Köse

  • 1Hacettepe University Department of Pediatric Neurology, Ankara, Turkey.

Journal of Child Neurology
|December 16, 1998
PubMed

Insights

Beta-interferon combined with inosiplex showed potential in stabilizing subacute sclerosing panencephalitis (SSPE) in some patients. Longer treatment durations (over 2 months) appeared more effective for this rare neurological disease.

Area of Science:

  • Neurology
  • Virology
  • Immunology

Background:

  • Subacute sclerosing panencephalitis (SSPE) is a rare, progressive neurological complication of measles virus infection.
  • Current treatment options for SSPE are limited, with a poor prognosis.

Purpose of the Study:

  • To evaluate the efficacy of beta-interferon and oral inosiplex in treating subacute sclerosing panencephalitis.
  • To assess the correlation between clinical outcomes and changes in EEG, MRI, and CSF measles antibody levels.

Main Methods:

  • A cohort of seven SSPE patients received treatment with beta-interferon and inosiplex for 2 to 15 months.
  • Clinical status, electroencephalograms (EEG), magnetic resonance images (MRI), and cerebrospinal fluid (CSF) measles antibody levels were monitored.

Main Results:

  • Three patients showed stabilization or improvement; two others stabilized.
  • Two patients experienced disease progression and died.
  • Treatment durations less than 2 months were ineffective.
  • No close correlation was found between clinical course and changes in EEG, MRI, or CSF measles antibody levels.

Conclusions:

  • Beta-interferon may be an effective treatment for some SSPE patients.
  • Further larger studies with longer follow-up are warranted to confirm efficacy.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...